Invention Grant
- Patent Title: Chelating platform for delivery of radionuclides
-
Application No.: US16329178Application Date: 2017-08-28
-
Publication No.: US11235076B2Publication Date: 2022-02-01
- Inventor: Roland K. Strong , Peter Rupert , Rebecca J. Abergel , Ilya Captain , Gauthier J P Deblonde
- Applicant: Fred Hutchinson Cancer Research Center , The Regents of the University of California
- Applicant Address: US WA Seattle; US CA Oakland
- Assignee: Fred Hutchinson Cancer Research Center,The Regents of the University of California
- Current Assignee: Fred Hutchinson Cancer Research Center,The Regents of the University of California
- Current Assignee Address: US WA Seattle; US CA Oakland
- Agency: Lee & Hayes PC
- Agent C. Rachal Winger
- International Application: PCT/US2017/048954 WO 20170828
- International Announcement: WO2018/044812 WO 20180308
- Main IPC: A61K51/04
- IPC: A61K51/04 ; B01D15/34 ; B01D15/38 ; C07K14/47 ; C22B60/02
Abstract:
Siderocalin-metal chelator combinations that bind metallic radioisotopes used in nuclear medicine with high affinity are described. The high affinity siderocalin-metal chelator combinations include a number of chelator backbone arrangements with functional groups that coordinate with metals. The siderocalin-metal chelator combinations can be used to deliver radionuclides for imaging and therapeutic purposes.
Public/Granted literature
- US20190184041A1 CHELATING PLATFORM FOR DELIVERY OF RADIONUCLIDES Public/Granted day:2019-06-20
Information query
